[{"id":"c20d356d-7859-447f-92f5-4a3c20d46eea","acronym":"ASN004","url":"https://clinicaltrials.gov/study/NCT04410224","created_at":"2023-10-31T16:12:25.506Z","updated_at":"2024-07-02T16:35:17.878Z","phase":"Phase 1","brief_title":"Study of ASN004 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT04410224 - ASN004","lead_sponsor":"Kirilys Therapeutics Inc.","biomarkers":" TPBG","pipe":" | ","alterations":" TPBG expression","tags":["TPBG"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TPBG expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRLS-004"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 19","initiation":"Initiation: 04/08/2022","start_date":" 04/08/2022","primary_txt":" Primary completion: 06/30/2024","primary_completion_date":" 06/30/2024","study_txt":" Completion: 09/30/2024","study_completion_date":" 09/30/2024","last_update_posted":"2024-02-23"}]